Last synced on 18 April 2025 at 11:05 pm

Beta 2-Microglobulin Apheresis Column

Page Type
Product Code
Definition
Relief of symptoms of clinically diagnosed dialysis-related amyloidosis (DRA).
Physical State
The Beta 2-microglobulin Apheresis Column is an adsorbent column containing porous, spherical cellulose beads with covalently linked hexadecyl groups as ligands. The size of the pores on the beads is about 460 um. The device comes in multiple models with capacity ranging from 150 ml to 350 ml and extracorporeal volume ranging from 65 ml to 177 ml.
Technical Method
The device adsorbs Beta 2-microglobulin by the combined use of hydrophobic interaction and the appropriate pore size on cellulose beads. The pore size limits the size of proteins and peptides adsorbed by the column to be between 4 and 20 kDa.
Target Area
External communicating device in contact with circulating blood.
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PDI to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Beta 2-Microglobulin Apheresis Column

Page Type
Product Code
Definition
Relief of symptoms of clinically diagnosed dialysis-related amyloidosis (DRA).
Physical State
The Beta 2-microglobulin Apheresis Column is an adsorbent column containing porous, spherical cellulose beads with covalently linked hexadecyl groups as ligands. The size of the pores on the beads is about 460 um. The device comes in multiple models with capacity ranging from 150 ml to 350 ml and extracorporeal volume ranging from 65 ml to 177 ml.
Technical Method
The device adsorbs Beta 2-microglobulin by the combined use of hydrophobic interaction and the appropriate pore size on cellulose beads. The pore size limits the size of proteins and peptides adsorbed by the column to be between 4 and 20 kDa.
Target Area
External communicating device in contact with circulating blood.
Review Panel
Gastroenterology and Urology
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code PDI to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.